Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate


Monday, May 4, 2015

Entering Leg 2 of syringe exchange triathlon

With law enacted, implementation adheres to prescribed steps

Indiana is about to legalize syringe exchange. This herculean bipartisan effort, led by Rep. Ed Clere, R-New Albany, enacted evidence-based public health policy in a state with a long-starved public health system.

As triathlons go, the syringe exchange legislative process was a tough first leg that will be followed by a second leg of policy implementation and a final leg of impact evaluation. We are now at T1 – that transition between Legs 1 and 2. And Leg 2 will be challenging.

Syringe exchange is part of a comprehensive public health effort to reduce HIV and hepatitis C among drug-injecting populations. Programs “exchange” sterile for used syringes, and link participants to screening and treatment for Hepatitis C and HIV, as well as substance abuse treatment. Studies over the past 30 years have demonstrated their effectiveness at reducing hepatitis C and HIV.

Read more...
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)